CADTH is committed to supporting Canada’s health care decision-makers through this challenging and uncertain time.
For evidence, tools, and resources related to COVID-19, visit our COVID-19 Evidence Portal.

 

Begin main content

Open Calls for Patient and Clinician Input

Listed are current opportunities for patient groups, clinician groups, drug plans, and cancer agencies to provide input or feedback on drugs being assessed within the reimbursement review process.

At CADTH, input is information, insight, or advice given to CADTH to contribute to a review. Feedback is a response to a prepared proposal, review report, or draft recommendation.

Evenity (romosozumab)

Therapeutic Area: Osteoporosis, postmenopausal women

Call For Patient Input: January 4, 2021

Patient Input Closed: February 26, 2021

Perseris (risperidone )

Therapeutic Area: Schizophrenia, adults

Call For Patient Input: December 24, 2020

Patient Input Closed: February 22, 2021

TBC (luspatercept )

Therapeutic Area: Myelodysplastic syndromes-associated anemia

Call For Patient Input: December 23, 2020

Patient Input Closed: February 22, 2021

(TBC) (budesonide/ glycopyrronium /formoterol fumarate )

Therapeutic Area: chronic obstructive pulmonary disease (COPD)

Call For Patient Input: December 23, 2020

Patient Input Closed: February 22, 2021

Entuzity KwikPen (human insulin)

Therapeutic Area: Diabetes mellitus

Call For Patient Input: December 22, 2020

Patient Input Closed: February 22, 2021

Venclexta (venetoclax)

Therapeutic Area: Acute myeloid leukemia

Call For Patient Input: December 17, 2020

Patient Input Closed: February 12, 2021

TBC (elexacaftor/tezacaftor/ivacaftor and ivacaftor)

Therapeutic Area: Cystic fibrosis, F508del CFTR mutation

Call For Patient Input: December 17, 2020

Patient Input Closed: February 12, 2021

TBC (daunorubicin and cytarabine)

Therapeutic Area: Acute myeloid leukaemia

Call For Patient Input: December 17, 2020

Patient Input Closed: February 12, 2021

Keytruda (pembrolizumab)

Therapeutic Area: Classical Hodgkin lymphoma

Call For Patient Input: December 10, 2020

Patient Input Closed: February 5, 2021

Venclexta (Venetoclax)

Therapeutic Area: Acute myeloid leukemia

Call For Patient Input: December 3, 2020

Patient Input Closed: January 29, 2021

Rinvoq (upadacitinib)

Therapeutic Area: Psoriatic Arthritis, Adults.

Call For Patient Input: November 27, 2020

Patient Input Closed: January 29, 2021

Saxenda (liraglutide)

Therapeutic Area: Chronic weight management in adults

Call For Patient Input: November 26, 2020

Patient Input Closed: January 22, 2021

Ledaga (chlormethine hydrochloride)

Therapeutic Area: T-cell lymphoma

Call For Patient Input: November 23, 2020

Patient Input Closed: January 22, 2021

TBC (brexucabtagene autoleucel)

Therapeutic Area: Mantle cell lymphoma

Call For Patient Input: November 20, 2020

Patient Input Closed: January 22, 2021